Vendor profile
Boehringer Ingelheim Portugal, Lda
PT- Awards
- 6
- Total awarded value
- €764,982
- Countries
- countries.PT
- Latest award
- Jul 14, 2026
- Expiring within 12 months
- 0
Award history
| Date | Buyer | Title | Value | Country | Expires |
|---|---|---|---|---|---|
| 07/14/2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Pharmaceutical products – 2025/1589 - NINTEDANIB [150MG CÁPS] | €3.8K | PT | — |
| 07/14/2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Pharmaceutical products – 2025/1589 - NINTEDANIB [150MG CÁPS] | €18.6K | PT | — |
| 07/14/2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Pharmaceutical products – 2025/1589 - NINTEDANIB [150MG CÁPS] | €252.9K | PT | — |
| 07/01/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491- NINTEDANIB [100MG; CÁPS] | €336.9K | PT | — |
| 07/01/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491- NINTEDANIB [100MG; CÁPS] | €67.8K | PT | — |
| 07/01/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491- NINTEDANIB [100MG; CÁPS] | €85.0K | PT | — |